Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

GAMAVAN 360 MICROGRAMOS/ML SOLUCION ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/GAMAVAN 360 MICROGRAMOS/ML SOLUCION ORAL

Approved

STANDARD

GAMAVAN 360 MICROGRAMOS/ML SOLUCION ORAL

Gp Pharm S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 23, 2020
Approval ID: d7341b8f1afbecbf
Company: Gp Pharm S.A.
Type: Standard

Approval Details

Approval Id: d7341b8f1afbecbf
Drug Cima Aemps Name: GAMAVAN 360 MICROGRAMOS/ML SOLUCION ORAL
Register Number: 85270
Holder Company Name: Gp Pharm S.A.
Marketing Company Name: Gp Pharm S.A.
Authorization Date: 2020-07-23
Dosage Form: SOLUCIÓN ORAL
Dose: 360 microgramos/ml
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Gp Pharm S.A.

Active Ingredients

DESMOPRESINA ACETATO

6 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 23, 2020

Approval ID

d7341b8f1afbecbf

Type

Standard

Back to CIMA-AEMPS Approvals